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Objective: The lymphatic vascular system exerts major physiological functions in the 
transport of interstitial fluid from peripheral tissues back to the blood circulation and 
in the trafficking of immune cells to lymph nodes. Previous studies in global 
constitutive knockout mice for the lymphatic transmembrane molecule podoplanin 
reported perinatal lethality and a complex phenotype with lung abnormalities, cardiac 
defects, lymphedema, blood-filled lymphatic vessels and lack of lymph node 
organization, reflecting the importance of podoplanin expression not only by the 
lymphatic endothelium, but also by a variety of non-endothelial cell types. Therefore, 
we aimed to dissect the specific role of podoplanin expressed by adult lymphatic 
vessels. 
Approach and Results: We generated an inducible, lymphatic-specific podoplanin 
knockout mouse model (PdpnΔLEC) and induced gene deletion postnatally. PdpnΔLEC 
mice were viable and their lymphatic vessels appeared morphologically normal with 
unaltered fluid drainage function. Intriguingly, PdpnΔLEC mice had blood-filled lymph 
nodes and vessels, most frequently in the neck and axillary region, and displayed a 
blood-filled thoracic duct, suggestive of retrograde filling of blood from the blood 
circulation into the lymphatic system. Histological and FACS analyses revealed 
normal lymph node organization with the presence of erythrocytes within lymph node 
lymphatic vessels but not surrounding high endothelial venules. Moreover, FITC 
painting experiments revealed reduced dendritic cell migration to lymph nodes in 
PdpnΔLEC mice. 
Conclusions: These results reveal an important role of podoplanin expressed by 
lymphatic vessels in preventing postnatal blood filling of the lymphatic vascular 
system and in contributing to efficient dendritic cell migration to the lymph nodes. 
 
NON-STANDARD ABBREVIATIONS AND ACRONYMS 
LN  lymph node 
LV  lymphatic vessel 
LVV  lymphovenous valve 
TD  thoracic duct 
LECs  lymphatic endothelial cells 
FRCs  follicular reticular cells 
CLEC-2 C-type lectin-like receptor 2 
DCs  dendritic cells 





The lymphatic vascular system is responsible for tissue fluid homeostasis, immune 
cell trafficking and intestinal lipid uptake.1, 2 Peripheral lymphatic capillaries take up 
interstitial fluid (i.e. lymph) that is then filtered through lymph nodes (LN) and drained 
by lymphatic collecting vessels that converge into the thoracic duct (TD) - the largest 
lymphatic vessel (LV) in the body - and the right lymphatic trunk, which finally 
connect to the subclavian veins, where the lymph enters the blood circulation. At 
these connection points, specialized valves known as lymphovenous valves (LVV) 
prevent the flow of blood into the lymphatic circulation.3, 4 LVs also play key functions 
in the trafficking of immune cells from the peripheral tissues to the draining LNs, 
where the initiation of adaptive immune responses occurs.5 
Podoplanin is a small, extensively O-glycosylated, type-1 transmembrane protein 
expressed by lymphatic endothelial cells (LECs)6 but not by blood vascular 
endothelial cells and is therefore a widely used lymphatic specific marker. 
Podoplanin is also expressed by follicular reticular cells (FRCs) of secondary 
lymphoid organs7, podocytes of the kidney8, alveolar type-1 cells of the lung and by 
the choroid plexus epithelium9. Moreover, it is expressed in the developing heart of 
the mouse embryo.10 Podoplanin is the only described endogenous ligand of the C-
type lectin-like receptor 2 (CLEC-2)11, which is expressed by platelets12 and activated 
dendritic cells (DCs)13-15. CLEC-2 signaling is involved in platelet activation12, DC 
motility15 and in the maintenance of vascular integrity16, LN structure and 
development.17 
Podoplanin global knockout mice die shortly after birth, due to a failure to inflate their 
lungs.18, 19 Several studies described profound defects in the development and 
patterning of the lymphatic vasculature in these mice. Global podoplanin knockout 
mice display congenital lymphedema, impaired lymphatic function, dilation and 
mispatterning of the intestinal and cutaneous lymphatic vasculature, and blood-filled 
LVs.20-22 The latter phenotype has been attributed to the interaction, at midgestation, 
of podoplanin expressed by LECs with CLEC-2 expressing platelets, inducing 
platelet activation and formation of thrombi that mediate the proper separation of the 
nascent lymphatic system from the cardinal vein.22, 23 These mice also lack most of 
the LNs which are replaced by blood-filled, poorly organized remnants.24 Additionally, 
several cardiac defects, including hypoplasia of the myocardium, were described in 
podoplanin-deficient embryos25-27, and deletion of podoplanin at the 2-cell stage 
causes cerebral hemorrhaging in embryos.28 The broad expression of podoplanin, 
together with the lethal phenotype observed in global podoplanin-deficient mice, 
suggests an important role for podoplanin in diverse cell types and in the ontogeny of 
different organs. It has, however, not been possible thus far to dissect its direct 
function specifically in the lymphatic endothelium at late postnatal or adult stages.  
To specifically investigate the function of podoplanin in the postnatal lymphatic 
vasculature, we developed, for the first time, an inducible, lymphatic-specific 
podoplanin knockout mouse by crossing Pdpnfl/fl mice28 and Prox1-Cre-ERT2 mice29 
to obtain PdpnΔLEC mice. Postnatal deletion of podoplanin was compatible with life 
and did not affect the maintenance of normal LV morphology and function. Strikingly, 
however, blood was frequently detected in the thoracic duct (TD) of PdpnΔLEC mice. 
Moreover, a subset of their LNs, despite maintaining a normal organization, were 
frequently blood-filled with detection of blood within the LVs, whereas no disruption of 
high endothelial venule (HEV) integrity was observed. Furthermore, DC migration to 
LNs after FITC challenge was reduced in PdpnΔLEC mice, highlighting a role for 
podoplanin in immune cell trafficking to the LN. Taken together, these results 
suggest important postnatal functions of LV-expressed podoplanin in preventing 
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retrograde flow of blood into the lymphatic system and in regulating DC migration to 
LNs after challenge. 
METHODS 
Materials and Methods are available in the online-only Data Supplement. 
RESULTS 
Generation of a conditional, lymphatic-specific podoplanin knockout mouse model. 
Since global constitutive podoplanin knockout mice display a lethal phenotype on 
most genetic backgrounds, at least in part due to a failure to inflate their lungs,18 we 
generated mice with postnatal deletion of podoplanin specifically in the lymphatic 
vasculature. To this aim, Pdpnfl/fl mice28 were crossed with Prox1-Cre-ERT2 mice29, 
which express Cre recombinase under control of the lymphatic specification gene 
Prox130 upon tamoxifen administration, obtaining the PdpnΔLEC line (Figure 1A).  
Postnatal deletion of the podoplanin gene was induced by daily tamoxifen 
administrations from postnatal day (P) 1 to P3 (Figure 1A). Adult PdpnΔLEC mice 
showed efficient podoplanin downregulation in dermal LVs, as assessed by whole 
mount immunofluorescence stainings for podoplanin and the lymphatic marker 
LYVE-1 (Figure 1B and SID), and by FACS analysis (Figure 1C). PdpnΔLEC mice 
were monitored from birth until at least 23 weeks of age; they were not visually 
distinguishable from wild-type littermates and their weight was normal (data not 
shown).  
Postnatal deletion of podoplanin does not interfere with lymphatic patterning.  
At P7, PdpnΔLEC pups appeared normal and no difference in weight was observed 
(Figure 2A). Podoplanin was efficiently downregulated at this time point, as assessed 
by podoplanin whole-mount stainings of abdominal skin, diaphragm and mesentery 
(Figure SIA-C). LV morphology was analyzed by staining whole-mount preparations 
of abdominal skin (Figure 2B), tail skin (Figure 2C) and diaphragm (Figure 2D) for 
LYVE-1. Morphometric analyses did not reveal any significant differences in the 
LYVE-1+ area, number of branch points, number of ring structures, LV diameter, total 
vessel length and average and branch length; Figure 2 B-D).  
Adult lymphatic vessels are morphologically and functionally normal after postnatal 
deletion of podoplanin. 
Next, we investigated the morphology and functionality of adult LVs lacking 
podoplanin. To this purpose, ear whole-mounts of 11-weeks-old mice were stained 
for LYVE-1. LV morphology appeared normal in adult PdpnΔLEC animals, as no major 
differences were found in the tissue area covered by LVs, the number of LV 
branches, the total vessel length and the average vessel diameter (Figure 3A). As a 
measure of lymphatic function, we injected the lymphatic specific tracer P20D80031, 32 
intradermally into the ear and monitored its clearance by LVs over time. As quantified 
by half-life and K rate of the tracer decay, no difference was observed in lymphatic 
clearance between PdpnΔLEC mice and wild-type littermates (Figure 3B).  
Postnatal deletion of podoplanin results in blood-filled lymphatic vessels and lymph 
nodes.  
The LNs of adult PdpnΔLEC mice often displayed a bloody appearance (Figure 4A, 4C 
and SIIA-B). In order to determine when this phenotype arose, we analyzed animals 
at different ages, namely P7, P21 and adults. As shown by the phenotype 
frequencies in different anatomical locations (Figure 4B), at P7 the LNs were never 
blood-filled and we only observed blood in the thoracic duct of 1 out of 9 mice 
analyzed. At weaning age (P21), the phenotype was apparent and, as in adult mice, 
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the LNs located in the neck (auricular and mandibular) and axilla (axillary and 
brachial) showed the phenotype with higher frequency than the inguinal LNs and 
flank lymphatic collectors (Figure 4C). The mesenteric LNs (Figure SIIB) and 
intestinal LVs (Figure 4D) were blood-filled only in adult PdpnΔLEC mice and were not 
affected at P21 or P7. 
 FACS analysis revealed an increase in the frequency of red blood cells (identified as 
CD45- Ter119+ events) in auricular LNs harvested from adult PdpnΔLEC mice (7.7 ± 
2.17% of cells), as compared to wild-type littermates (1.3 ± 0.53%), confirming the 
presence of blood in these LNs (Figure 4E). 
To determine the origin of bleeding, we performed immunofluorescence analyses for 
red blood cells (Ter119), LYVE-1 and the pan-endothelial marker CD31 or VE-
cadherin on frozen LN sections (Figure 4F and SIIC-D). Red blood cells were 
detected inside CD31+/LYVE-1- HEVs (Figure 4F, arrowheads), but also inside LVs in 
PdpnΔLEC mice (Figure 4F, arrows and high power inset, Figure SIID). Importantly, no 
red blood cells were observed in the proximity of HEVs, suggesting that 
extravasation of erythrocytes from these vessels did not occur. Since FRCs lining 
HEVs retained podoplanin expression in PdpnΔLEC mice (Figure SIII, arrowheads), 
the presence of blood in the LNs was not due to compromised HEV integrity, but to 
blood filling of the lymphatic vasculature. 
We also analyzed the presence of blood in the TD of PdpnΔLEC mice, which was 
identified by fluorescent lymphatic tracing after intradermal injection of the lymphatic 
tracer P20D68031 in both hind paws. Blood was visible by white-light analysis in the 
TD in 36.4% (4 out of 11) of PdpnΔLEC mice (Figure 4G) but not in wild-type mice 
(n=7). In the majority of PdpnΔLEC mice (3 out of 4), the blood-filled TD was massively 
dilated (Figure 4G). Importantly, only mice that showed blood in the TD also had 
blood-filled mesenteric LNs (Figure SIB). Taken together, these data suggest that 
lack of podoplanin on LECs results in retrograde flow of blood from the veins into the 
lymphatic system. 
In order to investigate whether podoplanin is required throughout life to prevent 
blood-filling of the lymphatic system, we induced gene deletion in adult mice by 5 
daily tamoxifen injections and analyzed the phenotype 5 days after the last tamoxifen 
injection (Figure SIVA). With this regimen, podoplanin expression was strongly 
reduced even though gene deletion was not complete, as a low level of podoplanin 
expression was detected in some dermal LVs by whole-mount staining (Figure SIVB). 
We did not observe any blood in the LNs, but in 1/3 mice blood filled the TD (Figure 
SIVC). These data indicate that podoplanin is required throughout life to keep the 
blood from entering the lymphatic system. 
Postnatal deletion of podoplanin does not compromise lymph node organization.  
Global podoplanin knockout mice have poorly organized LNs.24 To assess the 
contribution of LV podoplanin to LN organization, we analyzed the morphology of 
PdpnΔLEC LNs in more detail. Histological analyses revealed normal B-cell follicle 
organization in PdpnΔLEC LNs, as compared to wild-type controls (Figure 5A). Ear 
draining LNs of PdpnΔLEC mice were heavier, while the total leukocyte number 
measured after RBC lysis, the proportions of T cells and the absolute number of 
migratory DCs did not differ between the genotypes (Figure 5B-F). We also analysed 
HEVs by immunostaining for the differentiation marker MECA-79 and observed a 
normal HEV morphology in LNs of PdpnΔLEC mice (Figure 5G). 
We found heavier LNs in PdpnΔLEC mice than in wild-type controls (Figure 5B). To 
assess the relative contribution of the presence of RBC and of the accumulation of 
fluid to the increased weight observed, we analysed the wet weight and dry weight of 
mandibular LNs and calculated the LN fluid content. Both the wet and dry LN weights 
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were increased in PdpnΔLEC mice as compared to wild-type controls, and the LN fluid 
content did not differ between the genotypes (Figure 5H). These data, together with 
the results on total LN cellularity (Figure 5C), indicate that the presence of RBC is 
responsible for the increased LN weight observed in PdpnΔLEC mice. 
Postnatal deletion of podoplanin impairs dendritic cell migration. 
It has been suggested that CLEC-2 deficiency hampers DC migration to the LN.15 To 
investigate if the CLEC-2 binding partner podoplanin on LVs contributes to efficient 
DC trafficking to the LN, we applied FITC solution to the ears of mice and analyzed 
its uptake by DCs and their migration to the draining auricular LNs after 18 hours 
(Figure 6A). We found reduced proportions of FITC+ DCs (gated as MHCII+ CD11c+ 
cells) in the LNs of PdpnΔLEC mice as compared to wild-type controls (Figure 6B). 
This reduction was a consequence of impaired DC migration, as there were no 
differences in the proportion of CD11b+ CD11c+ dermal DCs in the ear skin of 
PdpnΔLEC mice (Figure 6C). FACS analysis confirmed that LN DCs expressed CLEC-
2 and that PdpnΔLEC mice retained normal CLEC-2 expression (Figure 6D).  
DISCUSSION 
Podoplanin is a marker of lymphatic endothelium but is also expressed by other cell 
types such as LN FRCs and alveolar type-I cells in the lung (reviewed by Astarita et 
al.33). Thus, global constitutive podoplanin-deficient mice display a complex 
phenotype characterized by death at birth due to lung abnormalities, heart defects, 
lack of most LNs, edema and blood-filled LVs.18, 20, 22, 24, 26 Here, for the first time, we 
generated and characterized a mouse model for the postnatal deletion of podoplanin 
specifically in LVs.  
Podoplanin is the only described endogenous ligand of CLEC-211 and this 
biochemical interaction has been investigated in detail. The extracellular portion of 
podoplanin contains conserved domains required for CLEC-2 engagement34, which 
in platelets results in the phosphorylation of the CLEC-2 cytoplasmic tail, activation of 
the Syk tyrosine kinase and consequent downstream signaling via SLP-76 and 
PLCγ2, leading to platelet activation.11 It has been proposed that during embryonic 
development, podoplanin/CLEC-2 induced platelet activation prevents the blood-
filling of the budding lymphatic system from the cardinal vein (reviewed by Bertozzi et 
al. 35). Indeed, mice lacking either podoplanin, CLEC-2 or downstream signaling 
molecules such as Syk and SLP-76, all display a similar blood-filled lymphatic 
phenotype.21-23, 36-39 We induced podoplanin-deletion during early postnatal days (P1 
to P3) since at this time point, the lymphatic system has already separated from the 
cardinal vein, and lymphatic plexuses are actively maturing in different organs.40 We 
did not observe lethality or gross developmental defects up to 23 weeks of age in 
PdpnΔLEC animals, suggesting that postnatal deletion of podoplanin in lymphatic 
endothelium is compatible with life.  
Analysis of P7 pups and adult mice revealed morphologically normal and functional 
LVs in PdpnΔLEC mice, suggesting that podoplanin does not play a major role in the 
postnatal maturation of LVs or in the maintenance of adult LV morphology and 
drainage function. Previous analyses of global constitutive podoplanin-deficient mice 
showed enlarged and disorganized LVs, as well as edema and impaired lymphatic 
function.20 Additionally, blocking of podoplanin function by administration of 
podoplanin-Fc during late embryonic development resulted in a less complex 
diaphragmatic lymphatic network in pups.41 Thus, it is likely that, early in 
development, podoplanin functionally contributes not only to the separation of the 
blood vascular and the lymphatic system, but also to LV patterning. However, our 
data indicate that after birth, podoplanin is dispensable for proper lymphatic vessel 
maintenance and drainage function. In global podoplanin-deficient mice, where 
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podoplanin is also deleted from LN FRCs, lymphatic function is likely impaired by the 
lack of LNs.24 In contrast, in PdpnΔLEC mice, LNs are present and are normally 
organized, indicating that podoplanin expressed by FRCs and not by LECs is 
responsible for the lack of LN organization observed in global constitutive 
podoplanin-deficient mice. 
The most striking phenotype observed in PdpnΔLEC mice was the presence of blood-
filled LN LVs especially in the neck and axilla (95.5% and 68.2% of adult PdpnΔLEC 
mice respectively) and, less frequently, flank collecting LVs (7.6% of adult PdpnΔLEC 
mice) and mesenteric LNs and intestinal LVs (31.8% and 10.6% of adult PdpnΔLEC 
mice respectively). Moreover, blood was present in the TD of 36.4% of adult 
PdpnΔLEC mice analyzed. Interestingly, LN LVs were never blood-filled in P7 PdpnΔLEC 
mice (i.e., 5 days after the last tamoxifen injection) and only 11% of mice showed a 
blood-filled TD at this time point. At weaning age (P21), the frequency of the 
phenotype was similar to adult mice, with the exception of the mesenteric LNs and 
LVs, which were never blood-filled at this time point. These data suggest that, after 
podoplanin deletion, the blood takes a few weeks to reach the LN LVs and more 
distal sites, such as the mesentery. Accordingly, when gene deletion was induced in 
adult mice, LN LVs were not blood-filled 5 days after the last tamoxifen injection, but 
blood was detected in the TD of 1/3 of the mice, similarly to what we observed at P7 
after tamoxifen injections at P1 to P3. 
Moreover, the incomplete penetrance of this phenotype might be due to partial 
podoplanin deletion, which can occur when Cre recombination is induced after 
embryonic development.42 Efficient gene deletion relies on sufficient tamoxifen 
bioavailability in a given cell/organ, Cre promoter activity and expression levels of the 
target gene and local chromatin conformation at the loxP sites, and it is possible that 
these parameters vary between different cells.42-44  
Taken together, these data allowed us to propose a potential mechanism of the 
blood filling of LVs in PdpnΔLEC mice. The observation that the LNs located in the 
neck and axilla, which are anatomically closer to the LVVs, were filled by blood with 
the highest frequency, and that the phenotype was more pronounced in adult mice 
than at P7, suggests that LV expression of podoplanin regulates blood-lymph 
separation in adults and that loss of podoplanin likely compromises platelet 
aggregation in the proximity of the LVV, allowing filling of blood into the lymphatic 
system (Figure SV). Our observations confirm and extend a recent study that 
revealed an important function of platelet CLEC-2 in lymphovenous hemostasis.45 
Loss of CLEC-2 in the hematopoietic lineage using fetal liver chimeras, genetic 
approaches or antibody treatment caused filling of the TD with blood from the 
subclavian vein; thus, these mice displayed blood-filled mesenteric LNs and 
vessels.45, 46 Our study, for the first time, directly addresses the important role that 
podoplanin on LECs, as the molecular counterpart of CLEC-2, plays in controlling 
blood-lymphatic separation in developed animals. 
Several reports described blood-filled LNs and Peyer’s patches in adult mice lacking 
CLEC-2 specifically in the megakaryocyte/platelet lineage or after treatment with 
CLEC-2 depleting antibodies.16, 17, 45 However, in models of CLEC-2 deficiency, LN 
bleeding was also described to occur due to compromised HEV integrity.16 It was 
suggested that podoplanin on FRCs interacts with CLEC-2 expressing platelets, 
inducing release of sphingosine-1-phosphate that tightens inter-endothelial junctions 
in HEVs.16 Our immunofluorescence analyses of frozen LN sections in PdpnΔLEC mice 
revealed blood cells inside LVs of the LNs, but never in close proximity to HEVs. 
Moreover, FRCs normally lined HEVs and retained podoplanin expression in 
PdpnΔLEC LNs. These observations indicate that the blood-filled LN phenotype was 
 7 
not caused by disruption of HEV integrity, but solely by blood filling into the LVs of 
the LNs. 
The direct analysis of the LVV and the presence of thrombi in its proximity has been 
recently studied by whole-embryo histology 45. However, the investigation of this 
anatomical structure by histology in adult animals is technically challenging due to its 
deep location in the upper chest, and to the best of our knowledge, has not been 
described so far. Our detailed anatomical analysis of the affected LNs and major 
lymphatic vessels (i.e. the TD) that constitute the terminal end of the lymphatic 
system, together with the published data of models of CLEC-2 deficiency 45, strongly 
support our hypothesis that podoplanin functions at the interface between the 
lymphatic and the blood vascular system to prevent flow of blood into the lymphatic 
circulation postnatally (Figure SV). 
Despite the presence of blood-filled LVs in the LN, the lymphatic drainage function 
was not compromised in PdpnΔLEC mice under steady-state conditions, as evaluated 
by the clearance of an injected tracer from ear skin. Moreover, we could perfuse a 
lymphatic tracer into the blood-filled TD of PdpnΔLEC mice after intradermal injections 
into the hind paws. Similarly, Hess and colleagues observed fluorescence in the TD 
of CLEC-2 deficient animals after FITC-dextran injection in the hind limb, suggesting 
that forward lymphatic flow was present even when blood filled the lymphatic system 
in a model of CLEC-2 deficiency.45 It is possible that this residual forward flow is 
sufficient to ensure physiological fluid drainage in PdpnΔLEC and it would be of interest 
to test the drainage function in conditions characterized by increased demand of fluid 
drainage, such as inflammation. Another possible explanation could be that new 
alternate flow routes may be used to bypass the affected LNs, similarly to what has 
been described in metastasis bearing LNs.31  
Surprisingly, PdpnΔLEC mice do not show signs of distress or lethality, despite the 
presence of blood in the LVs. It is not uncommon that the presence of profound 
lymphatic defects does not translate in lethality; a remarkable example is the K14-
sVEGFR3 mouse line, which is viable despite completely lacking dermal LVs and 
displaying lymphedema 47. 
Importantly, we found a reduced DC migration to LNs in response to FITC challenge 
in PdpnΔLEC mice. It has been reported that CLEC-2 expressed by DCs interacts with 
podoplanin expressed by LECs and FRCs to induce actin cytoskeleton 
rearrangement and cell motility.15 Consequently, CLEC-2-/- fetal liver chimeras or 
mice lacking CLEC-2 specifically in CD11c+ DCs show reduced proportions of DCs 
migrating to the LNs.15, 48 Here, we complement these observations made in CLEC-2 
deficient mice and reinforce the importance of podoplanin expressed by LVs in DC 
migration. Importantly, we observed no differences in the number of migratory DCs 
present in PdpnΔLEC mice under steady-state conditions. Similarly, HEV maintenance, 
which has been linked to DC migration49, was not affected. These data suggest that 
CLEC-2 impacts on DC migration upon induction of inflammation and they are in 
agreement with published data showing no constitutive CLEC-2 expression in resting 
DCs, but upregulation upon LPS-induced systemic inflammation in a small subset of 
activated DCs.14 
Taken together, our study highlights an important role of podoplanin in adult 
lymphatic vessels: podoplanin prevents blood mixing into the lymphatic system 
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HIGHLIGHTS 
• Generation of the first inducible, lymphatic-specific, podoplanin knockout 
mouse model (PdpnΔLEC mice)  
• Postnatal loss of podoplanin in lymphatic endothelium results in blood-filled 
lymphatic vessels and lymph nodes without affecting lymphatic vessel 
patterning, morphology and drainage function of lymphatic vessels or lymph 
node organization 
• PdpnΔLEC mice show impaired dendritic cell migration to lymph nodes 
• Podoplanin on adult lymphatic vessels plays important functions in 





Figure 1. Generation of conditional, lymphatic-specific podoplanin knockout 
mice. A. Pdpnfl/fl mice were crossed with Prox1-Cre-ERT2 mice to obtain the 
PdpnΔLEC line. Postnatal gene deletion was induced by tamoxifen administration from 
postnatal day (P)1 to P3. B. Confocal z-stack images of whole-mount ear skin 
samples show that podoplanin was undetectable on LYVE-1+ LVs in adult PdpnΔLEC 
animals. Scale bars: 100 μm. C. Ear skin single cell suspensions were analyzed by 
FACS. LECs were gated as CD45- CD31+ LYVE-1+ events. Representative 
histograms of podoplanin expression on LECs isolated from adult PdpnΔLEC and wild-
type control mice are shown. The median fluorescence intensity (MFI) for podoplanin 
in the LEC gate was significantly lower in PdpnΔLEC samples. Mann-Whitney test, 
P<0.001. At least 6 mice per genotype were analyzed. 
 
Figure 2. Postnatal deletion of podoplanin does not interfere with lymphatic 
patterning. A. Comparable body weights of PdpnΔLEC mice and wild-type littermates 
at P7. Unpaired Student’s t-test, P>0.05. B. Confocal z-stack images of 
representative whole-mounts of abdominal skin samples stained for LYVE-1 (green). 
Quantification of the LYVE-1+ area and number of branch points per image showed 
no difference between genotypes. Mann-Whitney test, P>0.05. C. Confocal z-stack 
images of representative tail skin whole-mount samples stained for LYVE-1. 
Quantification of the LYVE-1+ area and the number of ring-like structures per image 
revealed no difference between genotypes. Mann-Whitney test, P>0.05. D. Confocal 
z-stack images of representative diaphragm segments stained for LYVE-1. 
Quantification of the LYVE-1+ area, number of branch points, total vessel length, 
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average vessel diameter and average branch length per diaphragmatic segment 
showed no difference between genotypes. Mann-Whitney test, P>0.05. Four to five 
animals per genotype from 4 independent litters were analyzed. Scale bars: 100 μm. 
 
Figure 3. Adult lymphatic vessels are morphologically and functionally normal 
after postnatal deletion of podoplanin. A. Confocal z-stack images of ear skin 
samples whole-mounts stained for LYVE-1 (red). Scale bar: 100 μm. Quantification 
of the LYVE-1+ area, number of branches, total vessel length and average vessel 
diameter showed no difference between genotypes. Mann-Whitney test, P>0.05. Six 
animals per genotype from independent litters were analyzed. B. IVIS images of ears 
injected intradermally with P20D800 tracer at several time points after injection. 
Clearance of the tracer by LVs was calculated as half-life and K rate and showed no 
difference between the two groups. Unpaired Student’s t-test, P>0.05. Each data 
point represents one injected ear. Six to eight animals per genotype were analyzed. 
 
Figure 4. Postnatal deletion of podoplanin results in blood-filled LVs and lymph 
nodes. A. Photograph of auricular LNs harvested from adult mice. PdpnΔLEC LNs 
appear blood-filled. Scale bar: 1 mm. B. Frequency of blood-filled LNs of the neck 
(auricular and mandibular), axilla (axillary and brachial), mesentery (mes) and 
inguinal (ing) regions and thoracic duct (TD) in PdpnΔLEC mice at different time points 
(P7 n=9; P21 n=5; adults n=66, n=11 for TD analysis; nd: not determined). C. Normal 
anatomy of the lymphatic flank collector and representative photograph of a PdpnΔLEC 
mouse displaying filling of the collector (arrowheads) with blood, from the axillary (ax) 
LN to the inguinal (ing) LN. Scale bars: 5 mm. D. Normal anatomy of the adult 
mesentery and representative photograph of a PdpnΔLEC mouse with blood-filled 
intestinal LVs. Scale bars: 1 mm (inset: 100 μm). E. Representative FACS plots of 
single cell LN suspensions stained for the red blood cell marker Ter119 and the 
leukocyte marker CD45. The frequency of red blood cells in PdpnΔLEC LNs was 
significantly higher than in wild-type LNs. Mann-Whitney test, **P<0.01 F. Confocal 
images of frozen sections of axillary LN stained for LYVE-1 (green), Ter119 (red) and 
CD31 (cyan). Red blood cells (red) filled LN LVs (green; arrows) in PdpnΔLEC samples. 
Red blood cells were also found inside HEVs (cyan; arrowheads) but never in their 
proximity. A minimum of 6 animals per genotype and condition were analyzed. Boxed 
area corresponds to higher power inset. Scale bars: 100 μm (inset: 25 μm). G. The 
fluorescent tracer P20D680 was used to identify the thoracic duct after injection into 
both hind paws. Blood was present in the TD of 36.4 % of PdpnΔLEC mice, scale bar: 
1 mm. 
 
Figure 5. Postnatal deletion of podoplanin does not compromise lymph node 
organization. A. Confocal tile-scan of axillary LNs stained for the B cell marker B220 
and with DAPI shows normal B-cell follicle organization in PdpnΔLEC mice. Scale bars: 
200 μm. B. Auricular LNs were significantly heavier in PdpnΔLEC mice. Unpaired 
Student’s t-test, **P<0.01. C. Total cellularity after red blood cell lysis showed no 
difference between genotypes. Mann-Whitney test, P>0.05. D. Total number of 
leukocytes (CD45+ cells) per LN was not different between genotypes. Mann-Whitney 
test, P>0.05. E. Proportions of T cells (% of CD3+ cells in CD45+ gate) did not differ 
between genotypes. Mann-Whitney test, P>0.05. F. Total number of migratory DCs 
(CD45+ MHCIIhigh CD11c+ cells) did not differ between genotypes. Mann-Whitney test, 
P>0.05. G. Representative confocal images of LN frozen sections stained for 
MECA79 (red) and podoplanin (green) revealed normal HEVs in PdpnΔLEC mice. 
Scale bars: 10 μm. H. Wet and dry weight of mandibular LNs were measured to 
calculate the fluid content. There was no difference in LN fluid content between the 
genotypes. Unpaired Student’s t-test, P>0.05. 
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Figure 6. Postnatal deletion of podoplanin impairs dendritic cell migration to 
LNs. A. Schematic representation of the FITC painting experiment: FITC solution 
was applied to the ears, and the draining auricular LNs were harvested and analyzed 
by FACS after 18 hours. B. Representative FACS dot plots (gated on MHCII+ events) 
showing MHCII+ CD11c+ FITC+ DCs in wild-type and PdpnΔLEC mice 18 hours after 
FITC application. Quantification of the proportions of MHCII+ CD11c+ FITC+ DCs in 
the auricular draining LNs 18 hours after FITC application showed a significant 
reduction in PdpnΔLEC mice. Mann-Whitney test, *P<0.05. Pooled data from 2 
independent experiments analyzing a total of 7 mice per genotype are shown. C. The 
proportions of CD45+ CD11b+ CD11c+ DCs in the ear skin did not differ between 
PdpnΔLEC and wild-type control mice. Mann-Whitney test, P>0.05. Left panel shows 
pooled data from 3 independent experiments analyzing a total of 11 mice per 
genotype. Right panel shows the mean value obtained in the 3 experiments. D. 
FACS analysis shows surface CLEC-2 expression on LN DCs (gated on CD45+ 
MHCII+ CD11c+ cells), histograms and delta median fluorescent intesities are shown. 
Wild-type and PdpnΔLEC mice express comparable levels of CLEC-2 (n=5). 
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